Clinical Trial Update: Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Doravirine + Dolutegravir as a dual therapy for HIV-1 infection in switch regimens; recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Doravirine + Dolutegravir Dual Therapy

Snippet

Sponsor: Chelsea and Westminster NHS Foundation Trust | Conditions: HIV-1-infection | Phase 3 | Status: RECRUITING